Search Results

5 Questions

Dr. Palmaz shares with us how he came to develop one of the most revolutionary devices in modern medicine.

By Julio Palmaz, MD

EVAR: A Perspective From Across the Pond

Roger Greenhalgh, MD, discusses endovascular practice in the United Kingdom and the bearing that upcoming trial results will have on the future of EVAR.

An Interview With Rodney White, MD

One of the world's foremost endovascular device experts discusses the reasons for the remarkable success of a relatively new technology and the promise it holds.

By Rodney White, MD

An Interview With Rodney White, MD

One of the world's foremost endovascular device experts discusses the reasons for the remarkable success of a relatively new technology and the promise it holds.

By Rodney White, MD

Global Perspectives on SFA Treatment: Argentina

By Esteban Mendaro, MD

The EVAR Landscape in 2011

A status report on AAA therapy.

By Frank J. Criado, MD, FACS, FSVM

The EVAR Revolution

An interview with Juan Parodi, MD

An Interview with Jacques Busquet, MD

The president of ISES explains the society's impact on the worldwide endovascular community and the current state of this specialty in France.

“Insui Shigen: When one drinks water, show respect to the person who dug the well.”

By Takao Ohki, MD, PhD, Chief Medical Editor

Pioneering Insights: Why EVAR's History Must Guide Its Future

Aortic experts and enthusiasts convened at the 2016 VERVE Symposium in Sydney, Australia, to reflect on the first 25 years of EVAR, as well as how past lessons can streamline modern innovation.

Thoracic Aortic Trauma: Who Gets Endovascular Intervention and How to Optimize Outcomes

The management of blunt thoracic aortic injury, from mechanism of injury and history of repair to indications for endovascular intervention, TEVAR techniques, and potential complications.

By Matthew Blecha, MD; Corinne Bunn, MD; Michael Soult, MD; and Vivian Gahtan, MD

An Interview With Frank J. Veith, MD

As Dr. Veith and the meeting that bears his name join forces with the Cleveland Clinic, he discusses the newly formed ISVS, board certification, and the evolution of vascular “surgery.”

By Frank J. Veith, MD

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

Who Determines Which Procedure Is Best?

How key industry leaders are removing device-manufacturer influence on patient procedures.

By Peter Gloviczki, MD

Superior Vena Cava Syndrome

An update on causes and treatments.

By Jonathan D. Grant, BS; Julie S. Lee, MD; Edward W. Lee, MD, PhD; and Stephen T. Kee, MD